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A functional Na+/K+-ATPase consists of a catalytic α subunit and a regulatory β subunit.
Four α isoforms of the Na+/K+-ATPase are found in mammals, each with a unique
expression pattern and catalytic activity. The α2 isoform, encoded by the ATP1A2
gene, is primarily found in the central nervous system (CNS) and in heart-, skeletal- and
smooth muscle tissues. In the CNS, the α2 isoform is mainly expressed in glial
cells. In particular, the α2 isoform is found in astrocytes, important for astrocytic K
+
clearance and, consequently, the indirect uptake of neurotransmitters. Both processes
are essential for proper brain activity, and autosomal dominantly mutations in the ATP1A2
gene cause the neurological disorder Familial hemiplegic migraine type 2 (FHM2).
FHM2 is a severe subtype of migraine with aura including temporary numbness or
weakness, and affecting only one side of the body. FHM2 patients often suffer from
neurological comorbidities such as seizures, sensory disturbances, cognitive impairment,
and psychiatric manifestations. The functional consequences of FHM2 diseasemutations
leads to a partial or complete loss of function of pump activity; however, a clear
phenotype-genotype correlation has yet to be elucidated. Gene-modified mouse models
targeting the Atp1a2 gene have proved instrumental in the understanding of the
pathology of FHM2. Several Atp1a2 knockout (KO) mice targeting different exons
have been reported. Homozygous Atp1a2 KO mice die shortly after birth due to
respiratory malfunction resulting from abnormal Cl− homeostasis in brainstem neurons.
Heterozygous KO mice are viable, but display altered behavior and neurological deficits
such as altered spatial learning, decreased motor activity and enhanced fear/anxiety
compared to wild type mice. FHM2 knock-in (KI) mouse models carrying the human in
vivo diseasemutationsW887R andG301R have also been reported. Bothmodels display
altered cortical spreading depression (CSD) and point to deficits in the glutamatergic
system as the main underlying mechanism of FHM2.
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THE NA+/K+-ATPase: EXPRESSION AND
FUNCTION
The Na+/K+-ATPase is a transmembrane ion-pump located at
the plasmamembrane of all mammalian cells. It’s function moves
three Na+ ions out of the cell and two K+ ions into the cell
utilizing energy from ATP hydrolysis (Skou, 1957).
A functional pump consists of a catalytic α-subunit and a
regulatory β-subunit (Kaplan, 2002). Four α-subunit isoforms,
designated as α1-α4, encoded by different genes are found in
mammals. Each α-subunit isoform has its own unique expression
pattern and catalytic activity, which can be modulated by the β-
subunit (Larsen et al., 2014; Hilbers et al., 2016). The ATP1A1
gene encodes the α1isoform, which is considered to be the
isoform that maintains basic cellular functions and is accordingly
expressed almost ubiquitously in all tissue and cell types (Lingrel
et al., 2007). The α2 isoform, encoded by the ATP1A2 gene, is
primarily expressed in the central nervous system (CNS) and in
heart-, skeletal,- and smooth muscle tissues. In the CNS, the α2
isoform is expressed primarily in astrocytes but also in other glial
cells (McGrail et al., 1991). During embryonic development, the
α2 isoform is expressed primarily in neurons, which gradually
changes to the glial cell expression pattern in the adult, murine
brain (McGrail et al., 1991; Cameron et al., 1994; Cholet et al.,
2002; Moseley et al., 2003).
The α3 isoform, encoded by the ATP1A3 gene, is also
expressed in the CNS and nervous tissue, but expresses
specifically in the neurons of the basal ganglia, cerebellum, and
hippocampus (McGrail et al., 1991; Bøttger et al., 2011; Li et al.,
2013).
General Na+/K+-ATPase activity is crucial for multiple
cellular functions such as maintaining resting membrane
potential, regulating cellular volume, regulating pH, and driving
the secondary active transport (Dobretsov and Stimers, 2005).
Regulated and specialized pump activity is important for normal
brain function. This is also reflected in the expressive relationship
between the α1, α2, and α3 isoforms in the CNS and the
complex neurological disorders caused by mutations in the
ATP1A2 and ATP1A3 genes (reviewed in Bøttger et al., 2012;
Heinzen et al., 2014). Furthermore, increased evidence suggests
roles for the Na+/K+-ATPase in regulating signaling pathways,
such as: the membrane-associated non-receptor tyrosine kinase
Src: activation of Ras/Raf/ERK1,2, phosphatidylinositol 3-kinase
(PI3K): PI3K-dependent protein kinase B, phospholipase C,
(Ca+2 )i oscillations (Aperia, 2007; Schoner and Scheiner-Bobis,
2007; Liu and Xie, 2010): and gene transcription (Egr-1, Fos, Jun,
Nr4a2, Hes1, and Gabre; Tupler et al., 2001).
THE α2 ISOFORM AND ITS FUNCTION IN
ASTROCYTES
Astrocytes are some of the most abundant cells in the CNS of
mammals, with a ratio of 1.4 astrocytes for every neuron in the
human cortex (Nedergaard et al., 2003). Through their physical
properties and neuron-glial signaling pathways, they play an
essential role in neuronal homeostasis through their physical
properties and neuron-glial signaling pathways. During neuronal
activity, a vast eﬄux of K+ ions into the extracellular space
occurs. The extracellular concentration of K+ ranges from 2.5
to 3.5mM in normal conditions but can increase to 50–80mM
under ischemic and cortical spreading depression events (Walz,
2000).
Since imbalances between extracellular K+ and K+ clearance
can affect neuronal excitability and abnormal brain function as
well as cause significant neuronal death. Even under conditions of
abundant glucose supply, extracellular K+ homeostasis must be
tightly regulated to support normal brain activity (Walz, 2000).
Spatial buffering plays a critical role in the mechanism of
K+ clearance (Karwoski et al., 1989; Walz, 2000; Kofuji and
Newman, 2004). This principle is based on the influx of K+ into
astrocytes though K+ channels, with the central channel being
Kir4.1, a member of the inward rectifier-type potassium channel
family. This positive influx then spreads electronically through
the cytoplasm of the astrocyte and exits again as K+ at locations
distant from the active neurons (Karwoski et al., 1989; Kofuji
and Newman, 2004; Macaulay and Zeuthen, 2012). In addition
to Kir4.1, both the Na
+/K+-ATPase and the Na+/K+/2Cl−
cotransporter 1 (NKCC1) are necessary for the import and export
of K+ in the astrocytes (Galvan et al., 1979; D’Ambrosio et al.,
2002; MacVicar et al., 2002; reviewed in Walz, 2000; Hertz et al.,
2015). This is further described elsewhere in this special issue by
MacAulay and colleagues.
In the Na+/K+-ATPase, the α2 isoform combined with the
β2 subunit have K
+ affinity and voltage-sensitivity. As a result
it is specifically geared to control extracellular K+ concentration
during intense neuronal firing (Larsen et al., 2014). Furthermore,
the α2 and β2 subunit isoforms are co-expressed and appears
to co-localize in astrocytes in the rodent brain (McGrail et al.,
1991; Fink et al., 1996; Knapp et al., 2000; Cholet et al., 2002).
Thus, the α2/β2 complex appears to be the main Na
+/K+-ATPase
constellation involved in the astrocytic K+ clearance (Larsen
et al., 2014).
Controlling the neurotransmitter levels present in the synapse
is required for functional neuronal signaling, plasticity and
neuroprotection. Removal of neurotransmitters occurs through
diffusion, enzymatic degradation, and the reuptake by neurons
and glial cells. The importance of astrocytic neurotransmitter
uptake is highlighted in mice deficient of the astrocytic glutamate
transporter excitatory amino acid transporter 2 (EAAT2), where
Eatt2-deficiency causes lethal spontaneous seizures and increased
susceptibility to acute cortical injury in mice (Tanaka et al.,
1997). The α2 isoform localizes predominately in astrocytes
and other glial cells (McGrail et al., 1991; Fink et al., 1996;
Knapp et al., 2000; Cholet et al., 2002) and has been shown
to co-distribute with both astrocytic glutamate transporters
excitatory amino acid transporter 1 (EAAT1) and EAAT2 (Cholet
et al., 2002). Additionally, the α2 isoform immunoprecipitated
with both EAAT1 and EAAT2 in rat cerebellar and forebrain
tissues, respectively (Rose et al., 2009). In the same study, it
was shown that the ouabain-mediated inhibition of Na+/K+-
ATPase activity had an inhibitory effect on glutamate uptake.
Another study similarly found the pump combination α2/β2 in
a protein complex with glutamate and lactate transports, thereby
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sustaining glutamate-dependent lactate transport (Kleene et al.,
2007). The uptake of glutamate via glutamate transporters
is driven by the Na+-gradient. Astrocytes, therefore, rely on
Na+,K+-ATPases to pump out accumulated Na+ (Grewer and
Rauen, 2005). The direct interaction between the α2 isoform
and astrocytic glutamate transporters highlights this dependency,
suggesting the existence of local regulation and crosstalk between
Na+/K+-ATPases activity and glutamate uptake. Based on the
dependency of many other neurotransmitter transporters on
the Na+-gradient, it is likely that the Na+/K+-ATPase is also
functionally linked to these transporters. Numerous studies have
shown a coupling between the α3 subunit and neurotransmitter
transport such as the glycine transporter GlyT2 (de Juan-Sanz
et al., 2013).
FAMILIAL HEMIPLEGIC MIGRAINE
Familial hemiplegic migraine (FHM) is an autosomal dominant
inherited migraine with aura and typically includes episodes
of temporary numbness or weakness affecting one side of the
body (hemiparesis). There are three recognized subtypes of FHM
(FHM1-3), each caused by distinctive mutations in a specific
gene. FHM Type 1, which accounts for around 50% of all FHM
cases, is caused by mutations in the CACNA1A gene encoding
the Cav2.1 P/Q voltage-dependent calcium channel (Ophoff et al.,
1996). FHM Type 2 is caused by mutations in the ATP1A2 gene
(De Fusco et al., 2003) and FHM type 3 is caused by mutations in
the SCN1A gene encoding the Na+ channel, voltage-gated, type
I, α subunit (Dichgans et al., 2005). Thus, all three types of FHM
are related to alterations in ion-transport and ion-homostasis.
FHM patients in general share common migraine associated
symptoms such as nausea, vomiting, and increased sensitivity
to stimuli such as sound and light. In addition, diverse
comorbidities have in addition been observed for each subtype
and also for different mutations in a given subtype. In FHM2,
observed neurological symptoms include sensory disturbance,
impaired vision during aura episodes, speech difficulties, varied
forms of epilepsy and seizures, developmental disabilities,
cognitive impairments and cerebellar defects, which cause
ataxia, dysarthria, and nystagmus. Rarer manifestations such
as psychiatric disorders (depression, borderline personality, and
obsessive-compulsive disorder), obesity, dystonic posturing, and
anxiety have also been reported (Barrett et al., 2008; Bøttger et al.,
2012; Ferrari et al., 2015).
The genetic linkage between ATP1A2 and FHM2 was first
made in 2003 (Marconi et al., 2003). In this study of two large
Italian families with extensive history of FHM2, the FHM2 locus
was narrowed to a 0.9 Mb region on chromosome 1q23 wherein
mutations in the ATP1A2 gene were first identified. Subsequent
sequence analysis of candidate genes revealed specific FHM2-
associated mutations in the ATP1A2 gene in each of the families
(De Fusco et al., 2003). Numerous new mutations in the ATP1A2
gene have been reported post-analysis, indicating that there are
more than 35 FHM2-associated mutations, spanning most of
the ATP1A2 coding region (Bøttger et al., 2012). Approximately
half of the FHM2 mutations tested in vitro show complete loss
of pump function, while a majority of the remainder showed
reduced pump activity relative to normal α2 pump activity.
A small number of mutations either prevent α2 expression or
prevent the transport of α2 to the plasma membrane (Bøttger
et al., 2012).
To date, genotype-phenotype correlations have yet to bemade,
yet it is likely that the severity of the main symptoms and the
spectra of comorbidities are linked to the effect of the mutation.
Due to the heterogeneity of human patients, however, it
may be impossible to correlate genotype-phenotype by clinical
patients studies. Therefore animal models are important tools
for understanding the spectrum of FHM2 phenotypes and to
elucidate the mechanisms behind FHM2.
GENE-MODIFIED α2 MOUSE MODELS
Several gene-modified mouse models targeting the Atp1a2 gene
have been reported, and extensively used to study the in vivo
functions of the α2 isoform (Table 1).
Only heterozygous α2 knock-out (KO) and knock-in (KI)
mice are viable, as homozygous mice dies immediately after birth
(James et al., 1999; Ikeda et al., 2003, 2004; Leo et al., 2011).
These immature deaths of homozygous mice were reportedly
caused by respiratory failure in α2
KOE2/KOE2 mice (Ikeda et al.,
2004). The activity of respiratory motor neurons in the fourth
cervical ventral root were altered in α2
KOE2/KOE2 fetuses, as
TABLE 1 | Atp1a2 gene modified mouse models.
Mouse
model*
Atp1a2 genetic
alteration
Major behavioral
observations
References
α2
+/KOE4 Deletion
targeting exon 4
- Enhanced fear
and anxiety
- Hypoactivity
- Impaired spatial
learning
James et al.,
1999; Lingrel et al.,
2007; Moseley
et al., 2007
α2
+/KOE21 Deletion
targeting exon
21
- Enhanced fear
and anxiety
Ikeda et al., 2003
α2
+/KOE2 Deletion
targeting exon 2
- Not assessed Ikeda et al., 2004
α2
+/W887R Single nucleotide
substitution
(T2763C)
causing a single
amino acid
substitution
(W887R)
- Enhanced fear
and anxiety
Leo et al., 2011
α2
+/G301R Single nucleotide
substitution
(G901A) causing
a single amino
acid substitution
(G301R).
- Hypoactivity
(females only)
- Compulsive
behaviors
(females only)
- Stress-induced
depression
Bøttger et al.,
2016
*Three Atp1a2 knock-out (KO) and two knock-in (KI) mice have been described. For all
five models, only heterozygous animals are viable after birth. No models of conditional
Atp1a2 KO in CNS related cells have been reported.
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the response of these neurons to electrical stimulation in the
ventrolateral medulla was significantly slower in homozygous KO
fetuses compared to wild type fetuses (Ikeda et al., 2004). A higher
intracellular Cl− concentration was found in these ventrolateral
medulla neurons in α2
KOE2/KOE2 fetuses. Furthermore, the α2
isoform co-immunoprecipitated with the K+-Cl− cotransporter
KCC2, suggesting a functional coupling (Ikeda et al., 2004;
Pedersen et al., 2006). This is supported by the fact that
homozygous Kcc2 KO mice also die immediately after birth
due to severe motor deficits that abolish respiration (Hübner
et al., 2001). Thus, homozygous α2
KOE2/KOE2 mice with a
complete loss of the α2 isoform function, exhibit severe deficits
in Cl− homeostasis in vulnerable cells including the respiratory
center neurons, thereby causing abnormal neuronal activity and
resulting in respiratory failure upon birth.
α2 ISOFORM KNOCK-OUT MICE
Relative to WT littermates, heterozygous α2
+/KOE21 and
α2
+/KOE4 mice showed a 50% reduction in the α2 isoform protein
levels (Ikeda et al., 2003; Moseley et al., 2007). The α1 isoform
protein levels were comparable between the two groups of mice,
whereas α3 isoform protein levels in α2
+/KOE4 mice were reduced
to 80% relative to WT (Moseley et al., 2007).
Both α2
+/KOE4 and α2
+/KOE21 mice models displayed
increased fear and anxiety behavior as the main abnormal
behavioral phenotype (Ikeda et al., 2003; Lingrel et al.,
2007; Moseley et al., 2007). Characteristic of these behavioral
phenotypes, the α2
+/KOE21 mice had fewer entries and spent
less time in the open arms in the elevated plus maze test (Ikeda
et al., 2003). In a similar zero maze test screening for fear and
anxiety, the same pattern was observed in in α2
+/KOE4 mice
(Moseley et al., 2007). Another common anxiety behavioral test
is the light/dark test, which consists of one illuminated room
connected to one dark room. The mouse to be tested is placed
in the dark room. The time of first entry into the illuminated
room and all subsequent periods of time spent in this room
are recorded. Compared to WT littermates, α2
+/KOE21 mice not
only spent significantly less time in the illuminated room, but
the latency to enter the illuminated room was also significantly
higher (Ikeda et al., 2003), indicating increased fear and anxiety
behavior phenotypes.
In the open field test, α2
+/KOE4 mice were found to be
overall less active compared to WT mice (Moseley et al., 2007).
In contrast, no altered spontaneous activity in home cage was
observed for the α2
+/KOE21 mice (Ikeda et al., 2003). This
suggests that the hypolocomotion observed in the open field
test was induced by the enhanced stress and anxiety response in
α2
+/KOE4 mice, caused by the unfamiliar and open environment
of the open field setup. This correlates with the observation
that α2
+/KOE4 mice spend more time in the periphery region
instead of the center region during the open field test, which is
a commonly used indicator of enhanced fear behavior (Moseley
et al., 2007).
Utilizing the Morris water maze test, α2
+/KOE4 mice were
also tested for spatial learning and memory (Moseley et al.,
2007). The latency to find the hidden platform was higher
for α2
+/KOE4 mice compared to WT, which normally indicates
impaired learning. However, the distance traveled to reach the
platform was comparable for α2
+/KOE4 andWTmice, suggesting
no impairment of spatial memory (Moseley et al., 2007). Thus,
the increased latency could be a consequence of the enhanced
fear and anxiety related behavior observed in α2
+/KOE4 mice,
as the immersion in water is highly stressful to the mouse. In
support of this, the α2
+/KOE21 mice display an increased freezing
time in conditioned fear stimuli, which suggests that learning and
memory capability is not impaired (Ikeda et al., 2003).
The enhanced fear and anxiety behavior was investigated
further in α2
+/KOE21 mice and homozygous α2
KOE21/KOE21
fetuses. It was found that homozygous α2
KOE21/KOE21 fetuses
displayed selective neuronal apoptosis in the amygdala and
piriform cortex, both regions involved in fear, anxiety and basic
defense mechanism behavior (Davis et al., 1994; Ikeda et al.,
2003). Furthermore, c-Fos expression was significantly elevated
in these regions in α2
KOE21/KOE21 fetuses and also in adult
α2
+/KOE21 mice after conditioned fear stimuli, which indicate
neuronal hyperactivity in the areas (Ikeda et al., 2003). An
increase in the excitability of amygdala output neurons increased
aversive fear conditioning (Davis et al., 1994), thus the enhanced
fear and anxiety behavior of α2 KO mice probably arise from
abnormal function of these brain regions.
Uptake of glutamate and GABA into crude synaptosome
preparations from α2
KOE21/KOE21 fetuses was impaired compared
to WT preparations and consequently, both glutamate and
GABA levels were increased in brains from α2
KOE21/KOE21 fetuses
relative to WT littermates (Ikeda et al., 2003). A dysfunction
in the removal of neurotransmitters from synapse could be the
underlying cause of neuronal hyperactivity and of the observed
neurodegeneration in the amygdala and piriform cortex. This
is further supported by other studies showing co-localization,
molecular interaction and functional interaction between α2 and
glutamate transporters (Cholet et al., 2002; Kleene et al., 2007;
Rose et al., 2009). It is reasonable to suggest that heterozygous
mice also share these abnormalities, which cause the observed
behavioral phenotypes in α2
+/KOE21 mice. Another plausible
explanation, as observed in α2
KOE2/KOE2 fetuses, is the α2
isoform interaction with KCC2 and altered intracellular Cl−
concentration, which appears to be the cause of respiratory
failure in α2
−/− mice (Ikeda et al., 2004; Pedersen et al., 2006).
This Cl− homeostasis deficit could result in enhanced fear and
anxiety behavior for all α2
+/− mice. Similar to the α2
+/KOE4
and α2
+/KOE21 mice, hypomorphic mice with 17% KCC2 levels
display increased anxiety-like behavior in several behavioral tests,
including the elevated-plusmaze test (Ikeda et al., 2003; Tornberg
et al., 2005; Moseley et al., 2007).
While most neurological studies involving the α2 subunit
focus on its effect in FHM2, several recent studies have also linked
the Na+/K+-ATPase to other critical neurological disorders such
as Amyotrophic lateral sclerosis (ALS), Huntington’s disease and
Alzheimer’s disease (Acuña et al., 2013; Valencia et al., 2013;
Gallardo et al., 2014; Ohnishi et al., 2015). In the ALS study,
the α2
+/KOE4 model was used to study the pathology of this
disease. A protein complex consisting of α2 and α-adducin
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was found enriched in cultured astrocytes expressing mutant
superoxide dismutase 1 (SOD1), the most common genetic factor
for ALS (Gallardo et al., 2014). Interestingly, knock down of α2
in cultured astrocytes protected co-cultured motor neurons from
degeneration, and mating α2
+/KOE4 and SOD1G93A mutant mice
significantly reduced neurodegeneration, thereby increasing the
lifespan of α2
+/KOE4− SOD1G93A mice compared to SOD1G93A
mice (Gallardo et al., 2014).
α2 ISOFORM KNOCK-IN MICE
Western blotting for α2 isoform protein in brain lysates showed
reduced α2 protein levels to around 60% in heterozygous adult
α2
+/W887R (Leo et al., 2011) and α2
+/G301R mice (Bøttger et al.,
2016) and to very minimal levels in homozygous fetuses of
α2
G301R/G301R. Specific brain regions were additionally probed in
the α2
+/G301R mice with similar results (Bøttger et al., 2016). No
alteration in the α1 and α3 subunit isoform protein levels was
found in either of the KI mouse models (Leo et al., 2011; Bøttger
et al., 2016), suggesting that these isoforms are not upregulated
to compensate for the haploinsufficiency of the α2 subunit in the
α2
+/W887R and α2
+/G301R mice.
Mutated α2-W887R transfected into HeLa cells was expressed
but did not properly transport to the cell surface. Instead,
it was found confined to the endoplasmic reticulum and
proteasome inhibition with MG132 increased α2-W887R levels
significantly (Leo et al., 2011). This suggests improper folding and
subsequently proteasomal degradation as the fate of α2-W887R.
However, transfection of α2-W887R into COS7 cells, showed α2-
W887R at the plasma membrane, by both immunofluorescence
staining and by subcellular fractionation (De Fusco et al., 2003).
Interestingly, α2-W887R located to the plasma membrane when
expressed in Xenopus laevis oocytes (Koenderink et al., 2005). On
measuring ion flux and ATPase activity, this W887R mutation
was shown to be inactive (Koenderink et al., 2005).
In vitro studies on α2-G301R found that this mutation did
not cause significant changes in mRNA stability as mRNA
levels in HeLa cells transfected with either α2 or α2-G301R,
respectively, were comparable (Santoro et al., 2011). However,
immunofluorescence staining for transfected α2-G301R showed
that the mutated version did not express properly. Thus, it was
concluded that this loss of function mutation prompts deficits
in folding, maturation, or intracellular trafficking of the α2-
G301R that causes it to be degraded (Santoro et al., 2011).
From these studies and the reduced α2 levels in α2
+/W887R and
α2
+/G301R mice, it appears reasonable to consider both mutated
pumps expressed but display no functional pump activity due
to improper transport and/or degradation. This is an important
difference to the KO models, since mutated α2 protein (α2-
W887R and α2-G301R) might still be able to interact with
important factors such as the β subunits that could have an effect
on the unmutated α2 isoform in these models.
The phenotypic behavioral consequences of introducing the
W887R mutation were assessed using a modified SHIRPA
protocol (Leo et al., 2011). In this protocol, few behavioral
differences were observed between α2
+/W887R andWTmice. The
only significant alteration between α2
+/W887R mice compared
to WT littermates was an elevated fear response and increased
anxiety (Leo et al., 2011).
Behavioral phenotypes were likewise addressed in the
α2
+/G301R mice. During the tail suspension test, for example,
the α2
+/G301R mice exhibited depression-like behavior, such
as increased immobility, compared to WT mice (Bøttger
et al., 2016). In a sucrose preference test, α2
+/G301R mice
displayed stress-induced anhedonia and increased acoustic startle
responses, implying abnormal levels of fear and anxiety (Bøttger
et al., 2016). Female α2
+/G301R mice were found to have
additional abnormal behavioral phenotypes compared to male
α2
+/G301R mice. Unlike WT females and male α2
+/G301R mice,
α2
+/G301R females were hypoactive in open field test (Bøttger
et al., 2016). Excessive grooming behaviors were also observed
in the open field, suggesting compulsive behavior in female
α2
+/G301R mice. The marble-burying test is one of the standard
behavioral tests for rodents to assess repetitive compulsive-
like behaviors. Female α2
+/G301R mice were found to display
obsessive compulsive disorder (OCD)-like traits as they buried
significantly more marbles compared to both WT and to male
α2
+/G301R mice.
Interestingly, these female-specific phenotypes were reverted
by a single progestin treatment, implying that the female
hormone cycle contributes to the altered behaviors noted in
α2
+/G301R females compared to WT females and male α2
+/G301R
mice. Intriguingly, this coincides with the influence of ovarian
hormones on migraines, and the higher prevalence of migraines
in women compared to men (Vos et al., 2012).
N-Methyl-D-aspartic acid or N-Methyl-D-aspartate
(NMDA)-receptor antagonists also reverted specific α2
+/G301R
phenotypes including hypoactivity, OCD-like behaviors and
increased acoustic stimuli startle response. This indicates that
the glutamatergic system is affected by the mutated α2 isoform.
In support of this, α2
+/G301R mice had elevated glutamate levels
in all major brain regions. Mixed astrocyte-neuron cultures
from α2
G301R/G301R mice displayed a significant reduction in
glutamate uptake compared to similar cultures from WT mice
(Bøttger et al., 2016). This further links the female sex hormone
cycle and the glutamate system to the comorbid psychiatric
manifestations of FHM2.
CORTICAL SPREADING DEPRESSION
A key characteristic of FHM2 is the appearance of the aura
phenomenon prior to the onset of the hemiplegic migraine.
It is widely accepted that cortical spreading depression (CSD)
is the molecular mechanism behind aura (Lauritzen et al.,
2011). CSD is a short-lasting wave of neuronal and glial cell
hyperactivity followed by a wave of long-lasting depression of
neuronal activity (Pietrobon and Moskowitz, 2013). During the
intense neuronal activity, excess K+ ions and glutamate are
released into the extracellular space. The inefficient removal
of K+ and glutamate by astrocytes can lead to wide-reaching
depolarization that depresses further neuronal firing (Lauritzen
et al., 2011; Pietrobon and Moskowitz, 2013). The CSD usually
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begins in the visual cortex and propagates slowly over the
cortex at a rate of 2–5mm/min (Pietrobon and Moskowitz,
2013).
In vivo CSD recordings revealed that α2
+/W887R mice were
more susceptible to CSD. This is based on a 35% decrease
in induction threshold relative to WT littermates (Leo et al.,
2011). Furthermore, induced CSD events in the α2
+/W887R
mice had a higher propagation velocity compared to WT
littermates (Leo et al., 2011). The duration of triggered CSD
events, however, was not altered between α2
+/W887R mice and
littermates (Leo et al., 2011). Electrocorticography in α2
+/G301R
mice, compared toWT littermates, revealed a prolonged recovery
phase following CSD (Bøttger et al., 2016). Further CSD assays
are necessary to conclude the effects of the G301R mutation
on CSD.
It is difficult to compare the CSD studies of the two
α2-KI mouse models, due to differing parameter and assay
conditions used in each study. Potassium acetate, for example,
was used for CSD induction in the right somatosensory
cortex in α2
+/G301R mice, whereas incremental electrical
current stimuli were delivered in the occipital cortex for the
α2
+/W887R mice. Moreover, the different use of anesthetics
(α-chloralose versus urethane) affects the data collection, as
previous studies of other anesthetics were shown to influence
the CSD induction threshold and to propagate speed differently
(Kudo et al., 2013). Furthermore, only male mice were used
in the α2
+/G301R study (Bøttger et al., 2016), whereas a
mixed sex population was used for the α2
+/W887R study (Leo
et al., 2011). In particular, considering the female specific
phenotypes of the α2
+/G301R, it appears that sex and specific
sex hormones play an important role in FHM2. To sufficiently
compare these two models and the CSD underlying FHM2,
a comparable study using the same CSD induction method,
same anesthetics and a focus on sex-specific phenotypes is
required.
The CSD abnormalities observed in both FHM2 models
are comparable with two FHM1 knock-in mouse models of
which revealed increased susceptibility to CSD compared to WT
mice. This further supports CSD as an important symptom of
migraines and FHM in general (van den Maagdenberg et al.,
2004, 2010). To further emphasize the importance of sex and
CSD, it was found that female FHM1 KI mice were more
susceptible to CSD than male KI mice (Eikermann-Haerter et al.,
2009). This sex difference was abolished with ovariectomy and
senescence, further solidifying the role of the female sex hormone
cycle, besides genetics, in the susceptibility to CSD (Eikermann-
Haerter et al., 2009).
PERSPECTIVES ON THE USE OF FHM2
MOUSE MODELS
Migraines affect nearly 15% of the world population, and while
FHM2 is a relatively rare migraine form, further insight into
FHM2 will lead to a broader understanding of migraines in
general (Vos et al., 2012). Animal models of human genetic
disorders are important tools for investigators in elucidating the
molecular and physiological deficits leading to the disorder. As
discussed in this review, much has already been learned from
existing Atp1a2 animal models (Ikeda et al., 2003, 2004; Lingrel
et al., 2007; Moseley et al., 2007; Leo et al., 2011; Bøttger et al.,
2016). The continued work with existing models and generating
of new models with different FHM2 mutations will expand our
understanding of FHM2. Further study of different FHM2mouse
models together with clinical descriptions of comparable FHM2
patients will shed light on any genotype-phenotype correlations,
a critical aspect when studying a disorder with varying symptoms,
severity, and different functional consequences of mutations.
FHM2 mouse models will be essential for drug development,
drug screening and drug testing for treatment of FHM2 patients.
A potential drug target for FHM2 is the Na+/K+-ATPase
itself because lost pump function and/or decreased/altered
pump activity is the main cause of FHM2 (Bøttger et al.,
2012). Since all FHM2 patients are heterozygous, targeting the
unmutated α2 isoformwith activators could potentially overcome
this haplodeficiency. In support of this therapeutic strategy,
a recent report showed that crossing a Atp1a3 mouse model
(Myskin) for Alternating Hemiplegia of Childhood (AHC) with
a mouse model overexpressing a WT Atp1a3 allele could rescue
the mutant phenotype through increased α3 pump activity
(Kirshenbaum et al., 2016). Modulating Na+/K+-ATPase is also a
desirable therapeutic strategy, due to this molecules’ localization
in the plasma membrane and well-regulated function. The
mechanism of regulation is via factors (e.g., the cardiac glycoside
ouabain) binding to the extracellular part of the pump.
An important aspect of Atp1a2 deficits appears to be the
resulting changes to the glutamatergic system. These changes
are manifested through molecular and histological interactions
between the mutant α2-subunit isoform and a glutamate
transporter (i.e., EAAT1 or EAAT2) or through reduced
glutamate uptake in cells with limited pump activity. Our data
suggests that future studies of mouse models with elevated
glutamate levels (e.g., α2-KO and -KI mice), which exhibit
reversion of key specific α2-KI phenotypes when targeted with
NMDA receptor antagonists (Cholet et al., 2002; Ikeda et al.,
2003; Rose et al., 2009; Bøttger et al., 2016), might prove beneficial
as a preclinical model to test drug targets within the glutamatergic
system in FHM2 patients.
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